XBiotech Inc.

Healthcare

NASDAQ:XBIT · NASDAQ Global Select

Market Cap $71.95M Beta 0.84 P/E (TTM) -1.8

$2.35 +0.43%

+$0.01 today

52W Low $2.09High $3.61

Vol 0.01M · Avg 0.03M

EPS (TTM) -$1.32Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-9.96%

Period High

$3.50

Period Low

$2.12

Latest

$2.35

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Relmada Therapeutics, Inc.

NASDAQ:RLMD

$487.67M

Adagene Inc.

NASDAQ:ADAG

$134.41M

Fortress Biotech, Inc.

NASDAQ:FBIO

$92.02M

Adicet Bio, Inc.

NASDAQ:ACET

$75.25M

Gain Therapeutics, Inc.

NASDAQ:GANX

$71.66M

TScan Therapeutics, Inc.

NASDAQ:TCRX

$55.71M

Acrivon Therapeutics, Inc. Common Stock

ACRV

$46.70M

Nutriband Inc.

NTRB

$41.21M

Lite Strategy, Inc.

LITS

$25.22M

CervoMed Inc.

CRVO

$22.68M

What is the latest XBIT filing?

The latest filing shown is 10-Q dated May 14, 2026.

How many recent filings does XBIT have?

Intrinsic Alpha currently shows 20 recent filings for XBIT.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.